Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (41-50 of 1,010) with videos related to

Pageof 101
Sort By:
The New England Journal of Medicine|September 22, 1994
Risks and benefits of antiarrhythmic therapyD M Roden
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 24, 2003
Genetic polymorphisms, drugs, and proarrhythmiaDan M Roden
Journal of Cardiovascular Electrophysiology|December 18, 2003
Antiarrhythmic drugs: past, present and futureDan M Roden
Circulation|December 24, 2003
Cardiovascular pharmacogenomicsDan M Roden
Journal of Cardiovascular Electrophysiology|May 12, 2006
Intracellular sodium overload: a system biology problem with implications for drug target identificationDan M Roden
Circulation Research|April 29, 2006
A new role for calmodulin in ion channel biologyDan M Roden
The Journal of Physiology|December 15, 2015
Predicting drug-induced QT prolongation and torsades de pointesDan M Roden
Trends in Cardiovascular Medicine|October 25, 2016
Editiorial Commentary: Genomics and drug discovery: The next frontier in precision medicineDan M Roden
Circulation|February 1, 1986
Pharmacologic information required for design of programmed electrical stimulation protocolsD M Roden
Clinical Pharmacology and Therapeutics|September 19, 2019
John A. Oates: A Founding Father of Clinical PharmacologyDan M Roden
Pageof 101

Showing results (41-50 of 1,010) with videos related to

Sort By:
Pageof 101
The New England Journal of Medicine|September 22, 1994
Risks and benefits of antiarrhythmic therapyD M Roden
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 24, 2003
Genetic polymorphisms, drugs, and proarrhythmiaDan M Roden
Journal of Cardiovascular Electrophysiology|December 18, 2003
Antiarrhythmic drugs: past, present and futureDan M Roden
Circulation|December 24, 2003
Cardiovascular pharmacogenomicsDan M Roden
Journal of Cardiovascular Electrophysiology|May 12, 2006
Intracellular sodium overload: a system biology problem with implications for drug target identificationDan M Roden
Circulation Research|April 29, 2006
A new role for calmodulin in ion channel biologyDan M Roden
The Journal of Physiology|December 15, 2015
Predicting drug-induced QT prolongation and torsades de pointesDan M Roden
Trends in Cardiovascular Medicine|October 25, 2016
Editiorial Commentary: Genomics and drug discovery: The next frontier in precision medicineDan M Roden
Circulation|February 1, 1986
Pharmacologic information required for design of programmed electrical stimulation protocolsD M Roden
Clinical Pharmacology and Therapeutics|September 19, 2019
John A. Oates: A Founding Father of Clinical PharmacologyDan M Roden
Pageof 101